Skip navigation

Strategies to Scale the Business and Best Practices for Accounting and Reporting

September 24-25, 2019
  • Boston, MA

CBI’s 3rd Annual Finance & Accounting for Bioscience Companies convenes professionals from growing, innovative life sciences organizations to discuss strategies to implement scalable financial reporting process, mitigate risk and develop lean and efficient finance teams. This meeting convenes nearly 200 senior-level executives and hones-in on the unique challenges faced by small and mid-sized biotech and pharmaceutical companies as they transition from private to public, enter into collaborations, cultivate talent and recognize revenue. Gain strategies to ensure regulatory compliance, train new team members, implement systems and effectively communicate financial performance.

Highlights for 2019 Include:

  • Update on changing technical accounting standards and regulations
  • Roadmap for new product launch and commercialization strategies for finance and accounting teams
  • Insight on financial systems, software and processes to gain efficiencies and effectiveness
  • Strategies for R&D collaborations and licensing deals
  • Case studies illustrating high growth and scalability of emerging biotech companies
  • Industry perspectives on third party risk, oversight of outsourced service providers and CRO partnership optimization
  • Best practices for recruiting and retaining top talent and technical expertise
  • Networking opportunities with elite speakers and industry thought leaders

Download the Conference Preview

Previous Attendee Acclaim:

Timely topics, excellent presenters, lively engaged audience and excellent networking opportunity!

The Finance and Accounting for Bioscience Companies conference was extremely well run with valuable
content and programming.

This was great! It was helpful to focus on topics that impact smaller biotechs. In particular, the interactive panels provided great perspectives.

This was a great conference. I enjoyed the technical learning sessions, then followed up with the industry panel discussions for participants to understand how these issues are incorporated into the real world.

The conference provided a great discussion and better understanding on relevant issues impacting us, while allowing participants to gain insights and best
practices from the speakers.

The conference addressed many hot topics that are faced by fast growing biotechs!

Thank you for the timely discussions on the changing accounting and SEC rules. Excellent opportunity
to learn from peers.

Great topics and incredible attendees.

3rd Annual Finance & Accounting for Bioscience Companies

Strategies to Scale the Business and Best Practices for Accounting and Reporting

CBI’s 3rd Annual Finance & Accounting for Bioscience Companies convenes professionals from growing, innovative life sciences organizations to discuss strategies to implement scalable financial reporting process, mitigate risk and develop lean and efficient finance teams. This meeting convenes nearly 200 senior-level executives and hones-in on the unique challenges faced by small and mid-sized biotech and pharmaceutical companies as they transition from private to public, enter into collaborations, cultivate talent and recognize revenue. Gain strategies to ensure regulatory compliance, train new team members, implement systems and effectively communicate financial performance.

Highlights for 2019 Include:

  • Update on changing technical accounting standards and regulations
  • Roadmap for new product launch and commercialization strategies for finance and accounting teams
  • Insight on financial systems, software and processes to gain efficiencies and effectiveness
  • Strategies for R&D collaborations and licensing deals
  • Case studies illustrating high growth and scalability of emerging biotech companies
  • Industry perspectives on third party risk, oversight of outsourced service providers and CRO partnership optimization
  • Best practices for recruiting and retaining top talent and technical expertise
  • Networking opportunities with elite speakers and industry thought leaders

Download the Conference Preview

Previous Attendee Acclaim:

Timely topics, excellent presenters, lively engaged audience and excellent networking opportunity!

The Finance and Accounting for Bioscience Companies conference was extremely well run with valuable
content and programming.

This was great! It was helpful to focus on topics that impact smaller biotechs. In particular, the interactive panels provided great perspectives.

This was a great conference. I enjoyed the technical learning sessions, then followed up with the industry panel discussions for participants to understand how these issues are incorporated into the real world.

The conference provided a great discussion and better understanding on relevant issues impacting us, while allowing participants to gain insights and best
practices from the speakers.

The conference addressed many hot topics that are faced by fast growing biotechs!

Thank you for the timely discussions on the changing accounting and SEC rules. Excellent opportunity
to learn from peers.

Great topics and incredible attendees.